IFNA1 and systemic lupus erythematosus: Advances in understanding the molecular mechanisms of innate immunity, with elucidation of the endosomal TLRs, have suggested that type I IFN, particularly IFN-α, is a central mediator in the pathogenesis of SLE [40].